Balyasny Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-277,414
| Closed | -$5.4M | – | 2117 |
|
|
2018
Q1 | $5.4M | Sell |
277,414
-393,168
| -59% | -$7.65M | 0.02% | 576 |
|
|
2017
Q4 | $11.2M | Buy |
670,582
+183,891
| +38% | +$3.06M | 0.03% | 521 |
|
|
2017
Q3 | $9.88M | Sell |
486,691
-564,793
| -54% | -$11.5M | 0.04% | 429 |
|
|
2017
Q2 | $16.9M | Buy |
1,051,484
+821,734
| +358% | +$13.2M | 0.07% | 323 |
|
|
2017
Q1 | $2.91M | Buy |
+229,750
| New | +$2.91M | 0.01% | 688 |
|
|
2016
Q2 | – | Sell |
-6,250
| Closed | -$200K | – | 1359 |
|
|
2016
Q1 | $200K | Buy |
+6,250
| New | +$200K | ﹤0.01% | 927 |
|
|
2014
Q1 | – | Sell |
-83,438
| Closed | -$2.1M | – | 585 |
|
|
2013
Q4 | $2.1M | Buy |
+83,438
| New | +$2.1M | 0.03% | 317 |
|